EUVIMEDEUVIMED entdecken
Kohortenstudie

0221 Impact of GLP-1 receptor agonists on the risk of inflammatory arthropathies in patients with hidradenitis suppurativa: A population-based cohort study

A. Ure, S. Aflatooni, J.A. Cortes, K. Smart, G. Palma, N.A. Johnsen, Y. Nong, A.W. Armstrong

Journal of Investigative Dermatology · 2026-08 · 146 (8) · S39

DOI: 10.1016/j.jid.2026.06.252 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von A. Ure und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ure, A., Aflatooni, S., Cortes, J., Smart, K., Palma, G., Johnsen, N., Nong, Y., & Armstrong, A. (2026). 0221 Impact of GLP-1 receptor agonists on the risk of inflammatory arthropathies in patients with hidradenitis suppurativa: A population-based cohort study. Journal of Investigative Dermatology, 146(8), S39. https://doi.org/10.1016/j.jid.2026.06.252

Vancouver

Ure A, Aflatooni S, Cortes J, Smart K, Palma G, Johnsen N, et al. 0221 Impact of GLP-1 receptor agonists on the risk of inflammatory arthropathies in patients with hidradenitis suppurativa: A population-based cohort study. Journal of Investigative Dermatology. 2026;146(8):S39. doi:10.1016/j.jid.2026.06.252

BibTeX
@article{Ure2026,
  author = {Ure, A. and Aflatooni, S. and Cortes, J.A. and Smart, K. and Palma, G. and Johnsen, N.A. and Nong, Y. and Armstrong, A.W.},
  title = {0221 Impact of GLP-1 receptor agonists on the risk of inflammatory arthropathies in patients with hidradenitis suppurativa: A population-based cohort study},
  journal = {Journal of Investigative Dermatology},
  year = {2026},
  volume = {146},
  number = {8},
  pages = {S39},
  doi = {10.1016/j.jid.2026.06.252}
}
Kostenlos starten →